Gala vs Trimi Health: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Gala beats Trimi Health overall, scoring 7.2/10 vs 4.2/10. Gala is more affordable at $149/mo vs $175/mo. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa. Choose Trimi Health for cash-pay patients who want the cheapest flat-price compounde.
A side-by-side look at Gala and Trimi Health to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Gala
#39 of 52Telehealth platform focused on compounded tirzepatide, both microdose and full-dose tiers, alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.
Visit GalaTrimi Health
#50 of 52Telehealth platform for compounded semaglutide and tirzepatide. Weekly injections in vial-and-syringe format only, no pens, no oral option. Pricing is flat across all doses, with the consult and overnight shipping included. Prescriptions route through the Arora Health medical group (Dr. Sean Arora MD, medical director) and are filled by VialsRx and GreenwichRx, the same backend that powers Telos RX. Founded May 2024 per the site's own schema markup; no legal entity suffix or street address is disclosed.
Visit Trimi Health| Feature | Gala | Trimi Health |
|---|---|---|
| Our Score | 7.2/10 | 4.2/10 |
| Starting Price | $149/mo | $175/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging | Cash-pay patients who want the cheapest flat-price compounded semaglutide we track ($99/mo on the annual plan) and will accept a weak Trustpilot record plus no-pro-rating cancellation terms in exchange |
| Ranking | #39 | #50 |
| Get started | Visit Gala | Visit Trimi Health |
Pros & Cons Compared
Gala
Pros
- +Microdose compounded tirzepatide at $149/mo, the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
- +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android, first-party in-treatment logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic pricing ($1,299/mo) is materially above market, NovoCare direct pricing for Wegovy is $349/mo, Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership
- −Tirzepatide-only on the compounded side, compounded semaglutide is NOT offered, narrower medication menu than peers like Maximus, Ro, or Henry Meds
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation typically a sync video visit, but ongoing follow-ups and questions are chat-based (no scheduled ongoing video access), and no published labs, no named medical director, no specialty obesity oversight
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Trimi Health
Pros
- +Flat pricing across all doses, your monthly price does not rise as your dose titrates up
- +$99/mo compounded semaglutide on the annual plan (billed $1,188 once yearly) is among the cheapest flat recurring rates we track; tirzepatide annual is $125/mo ($1,500 yearly)
- +Consult and overnight shipping included in the plan price, no add-on fees; HSA/FSA accepted, Klarna and Affirm financing available
- +Named medical director, Dr. Sean Arora MD of the Arora Health medical group, most compounded-only platforms name no one
- +Compounding pharmacies named: VialsRx (TX license #35264, site-claimed) and GreenwichRx, most competitors do not name theirs
- +Available in all 50 states plus DC per trytrimi.com/states
- +6-month money-back weight-loss promise published (conditions apply, read them before counting on it)
Cons
- −Trustpilot FELL from 4.6 earlier in 2026 to 3.4 across 71 reviews, ranking #62 of 70 in its category, recurring complaints cite account closures and withheld refunds
- −Once a prescription is signed, payments are final, no pro-rating, cancelling an annual plan mid-year forfeits the remainder. Full refund is available only BEFORE the prescription is signed
- −No legal entity disclosed, the site identifies only 'Trimi Health' with no LLC/Inc suffix and no street address (New York appears only in the site's schema markup)
- −Vial-and-syringe format only, no autoinjector pens, no oral option, no brand-name medications
- −LegitScript certification claimed but we could not verify it against LegitScript's registry
- −Mandatory arbitration clause in the terms
- −Retatrutide and orforglipron are listed as 'Preparing', roadmap items, not available today, do not enroll expecting them
- −Shares its medical group (Arora Health) and pharmacy (VialsRx) with Telos RX, a white-label backend relationship neither brand discloses on its own site
Our Verdict
Gala edges out Trimi Health with a score of 7.2/10 vs 4.2/10. If budget is your priority, Gala starts at $149/mo compared to Trimi Health's $175/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose Trimi Health if you want: cash-pay patients who want the cheapest flat-price compounded semaglutide we track ($99/mo on the annual plan) and will accept a weak trustpilot record plus no-pro-rating cancellation terms in exchange.
Still undecided? Editor's #1 Overall Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Gala nor Trimi Health feels like the right fit, our overall #1 pick across all 52 GLP-1 telehealth providers is TrimRx, strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing Gala or Trimi Health tend to look at next.
- Gala vs MEDVi$179/mo
- Gala vs bmiMD$119/mo
- Gala vs Found$129/mo
- Trimi Health vs TrimRx$149/mo
- Trimi Health vs Strut Health$149/mo
- Trimi Health vs Maximus$150/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.